Kura Oncology Announces Commencement of Public Offering of Common Stock


You May Also Like

Marinus Pharmaceuticals Provides Business Update and Second Quarter 2018 Financial Results

RADNOR, Pa., Aug. 02, 2018 (GLOBE NEWSWIRE) -- Marinus Pharmaceuticals, Inc. (Nasdaq:MRNS) (“Marinus” or ...

Celldex Reports First Quarter 2017 Results

HAMPTON, N.J., May 09, 2017 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) today reported ...